Injective (INJ) is currently priced at $3, reflecting a 24-hour decline of 2.22%. The daily range has been narrow, fluctuating between a high of $3.08 and a low of $2.98, indicating a lack of volatility in the short term.

The trading volume stands at approximately 43.8 million, representing 14.57% of its market cap. This volume level, while significant, does not suggest aggressive buying or selling pressure, as the price has continued to trend downward over the past week, with a 7-day price change of -5.37%.

Technical indicators reveal bearish momentum, with the 1-hour RSI at 48, suggesting a neutral sentiment in the very short term. However, the 7-day RSI at 46 indicates that INJ is nearing oversold conditions, which could present a potential buying opportunity if market sentiment shifts.

The moving averages also indicate bearish trends, with the 8, 13, 21, and 55 SMA all showing declines between 0.81% and 2.85%. The 144 SMA at $3.09 is also lower, emphasizing the prevailing downward trend in the price action.

In terms of price history, INJ reached an all-time high of $52.62 in March 2024, which highlights the current price's stark contrast to previous peaks. The significant drawdown from its all-time high suggests that investors remain cautious, as the 30-day price change stands at -15.86%.

Given the current price action, technical indicators, and overall sentiment, a Hold rating is appropriate. This reflects the potential for price recovery if market conditions improve, while also acknowledging the current bearish trend and lack of strong buying signals.